UNRV: AI-Bewertung 45/100 — AI-Analyse (Apr 2026)

Unrivaled Brands, Inc. cultivates, produces, distributes, and retails cannabis products in California, Oregon, and Nevada. The company operates medical marijuana retail and adult use dispensaries, cultivation, and production facilities.

Eckdaten: AI Score: 45/100 Sektor: Healthcare

Unternehmensueberblick

Kurzfassung:

Unrivaled Brands, Inc. operates within the cannabis industry, focusing on cultivation, production, distribution, and retail of medical and adult-use cannabis products. With operations in California, Oregon, and Nevada, the company manages dispensaries and cultivation facilities, positioning itself as a vertically integrated player in a competitive market.

Was macht UNRV?

Unrivaled Brands, Inc., formerly known as Terra Tech Corp., was established in 2010 and rebranded in July 2021 to reflect its evolved focus on the cannabis market. Headquartered in Santa Ana, California, the company operates as a vertically integrated cannabis business, engaging in cultivation, production, distribution, and retail. Unrivaled Brands manages medical marijuana and adult-use dispensaries across California, Oregon, and Nevada, complemented by its own cultivation and production facilities. This integrated approach allows the company to control its supply chain, ensuring product quality and consistency from seed to sale. The company's strategic presence in key cannabis markets positions it to capitalize on the growing demand for both medical and recreational cannabis products. Unrivaled Brands aims to establish a strong brand presence and customer loyalty through its diverse product offerings and retail experiences. The company's evolution from Terra Tech Corp. signals a strategic shift towards becoming a prominent player in the cannabis industry, adapting to the evolving regulatory landscape and consumer preferences.

Was ist die Investmentthese fuer UNRV?

Unrivaled Brands, Inc. presents a speculative investment opportunity within the cannabis sector, contingent on its ability to achieve profitability and navigate regulatory challenges. With a negative P/E ratio of -0.02 and a significant negative profit margin of -370.8%, the company's financial performance requires substantial improvement. The gross margin of 32.5% indicates potential for profitability if operational efficiencies are enhanced. Growth catalysts include expansion within existing markets and potential entry into new states as regulations evolve. Key risks involve intense competition, fluctuating cannabis prices, and the evolving legal landscape surrounding cannabis. The company's high beta of 2.71 suggests significant volatility relative to the market.

In welcher Branche ist UNRV taetig?

Unrivaled Brands, Inc. operates within the rapidly evolving cannabis industry, which is experiencing significant growth and regulatory changes. The market is characterized by increasing acceptance of cannabis for both medical and recreational use, driving demand and market expansion. However, the industry also faces challenges such as intense competition, varying state regulations, and federal prohibition. Unrivaled Brands competes with other cannabis companies, including both large multi-state operators and smaller local businesses. The company's success depends on its ability to differentiate its products, build brand loyalty, and navigate the complex regulatory environment.

Drug Manufacturers - Specialty & Generic

Healthcare

Welche Wachstumschancen hat UNRV?

Expansion within Existing Markets: Unrivaled Brands can focus on increasing its market share within California, Oregon, and Nevada by opening new dispensaries, expanding its product offerings, and enhancing its marketing efforts. The cannabis market in these states is projected to continue growing, providing opportunities for Unrivaled Brands to increase its revenue and profitability. The timeline for this growth is ongoing, with continuous efforts to optimize operations and expand market presence.
Entry into New Markets: As cannabis regulations evolve, Unrivaled Brands can explore opportunities to enter new states with favorable regulatory environments. This expansion would allow the company to diversify its revenue streams and reduce its reliance on existing markets. The timeline for this growth depends on regulatory changes and the company's ability to secure licenses and establish operations in new states. Market size varies by state, but the overall trend is towards increasing legalization and market growth.
Product Innovation and Development: Unrivaled Brands can invest in research and development to create new and innovative cannabis products that cater to evolving consumer preferences. This includes developing new strains, edibles, concentrates, and other cannabis-infused products. The timeline for product development varies depending on the complexity of the product, but ongoing innovation is essential to maintain a competitive edge. The market for new and innovative cannabis products is constantly expanding.
Strategic Partnerships and Acquisitions: Unrivaled Brands can pursue strategic partnerships and acquisitions to expand its operations, enhance its product offerings, and gain access to new markets. This includes partnering with other cannabis companies, technology providers, and retail operators. The timeline for partnerships and acquisitions depends on the availability of suitable targets and the company's ability to negotiate favorable terms. The market for cannabis-related acquisitions is active, with numerous opportunities for consolidation.
Increased Focus on Branding and Marketing: Unrivaled Brands can invest in building a strong brand identity and marketing its products effectively to reach a wider audience. This includes developing a consistent brand message, utilizing digital marketing channels, and participating in industry events. The timeline for branding and marketing efforts is ongoing, with continuous efforts to enhance brand awareness and customer loyalty. A strong brand can differentiate Unrivaled Brands from its competitors and drive sales growth.

Operates in California, Oregon, and Nevada, key states in the cannabis market.
Vertically integrated model encompassing cultivation, production, distribution, and retail.
Gross margin of 32.5% indicates potential for profitability with improved operational efficiency.
Market capitalization of $0.00B reflects its current valuation in the market.
Negative profit margin of -370.8% signals a need for significant financial turnaround.

Welche Produkte und Dienstleistungen bietet UNRV an?

Cultivates medical and adult-use cannabis.
Produces cannabis products, including flower, edibles, and concentrates.
Distributes cannabis products to retail locations.
Operates medical marijuana retail dispensaries.
Operates adult-use cannabis dispensaries.
Manages cultivation facilities.
Manages production facilities.

Wie verdient UNRV Geld?

Vertically integrated operations from cultivation to retail.
Generates revenue through the sale of cannabis products at its dispensaries.
Wholesale distribution of cannabis products to other retailers.

Medical marijuana patients.
Adult-use cannabis consumers.
Other cannabis retailers (wholesale).

Vertically integrated operations provide control over the supply chain.
Established presence in key cannabis markets (California, Oregon, Nevada).
Proprietary cultivation and production techniques.
Brand recognition and customer loyalty within its operating markets.

Was koennte die UNRV-Aktie steigen lassen?

Ongoing: Expansion of retail operations in existing markets.
Ongoing: Product innovation and development to meet evolving consumer preferences.
Upcoming: Potential regulatory changes in key states that could expand market access.
Ongoing: Strategic partnerships and acquisitions to enhance market position.
Ongoing: Branding and marketing efforts to increase brand awareness and customer loyalty.

Was sind die wichtigsten Risiken fuer UNRV?

Ongoing: Intense competition from other cannabis companies.
Ongoing: Fluctuating cannabis prices impacting profitability.
Potential: Changes in state and federal regulations impacting operations.
Potential: Limited access to capital due to the nature of the cannabis industry.
Ongoing: Negative profit margins and financial instability.

Was sind die wichtigsten Staerken von UNRV?

Vertically integrated operations.
Presence in key cannabis markets.
Established retail dispensaries.
In-house cultivation and production capabilities.

Was sind die Schwaechen von UNRV?

Negative profit margins.
High beta indicating volatility.
Dependence on evolving regulatory landscape.
Limited brand recognition compared to larger competitors.

Welche Chancen hat UNRV?

Expansion into new markets.
Product innovation and development.
Strategic partnerships and acquisitions.
Increasing acceptance of cannabis.

Welchen Risiken ist UNRV ausgesetzt?

Intense competition.
Fluctuating cannabis prices.
Changing regulatory environment.
Federal prohibition of cannabis.

Wer sind die Wettbewerber von UNRV?

Clarus Therapeutics Holdings, Inc. — Pharmaceutical company with a focus on men's health. — (CRXTQ)
Endo International plc — Specialty pharmaceutical company with a diverse portfolio of products. — (ENDP)
GW Pharmaceuticals plc — Focuses on cannabinoid-based medicines. — (GWPC)
Halo Health, Inc. — Unknown differentiation due to lack of available data. — (HHPHF)
NorCal Biosystems, Inc. — Unknown differentiation due to lack of available data. — (NLBS)

Key Metrics

MoonshotScore: 45/100

Company Profile

CEO: Sabas Carrillo
Headquarters: Santa Ana, US
Employees: 151
Founded: 2012

AI Insight

AI analysis pending for UNRV

OTC Tier: OTC Other
Disclosure Status: Unknown

Fragen & Antworten

What does Unrivaled Brands, Inc. do?

Unrivaled Brands, Inc. is a vertically integrated cannabis company that cultivates, produces, distributes, and retails medical and adult-use cannabis products. Operating in California, Oregon, and Nevada, the company manages its own cultivation and production facilities, as well as a network of retail dispensaries. This integrated model allows Unrivaled Brands to control its supply chain and ensure product quality, catering to both medical patients and recreational consumers in these key cannabis markets.

What do analysts say about UNRV stock?

AI analysis is pending for UNRV, so a current analyst consensus is unavailable. Investors should independently investigate UNRV's financial metrics, including its negative P/E ratio and profit margin, alongside its gross margin and market capitalization. Monitor company announcements and industry reports to assess growth opportunities and potential risks, considering the volatile nature of the cannabis market and the evolving regulatory landscape.

What are the main risks for UNRV?

Unrivaled Brands, Inc. faces several key risks inherent to the cannabis industry. These include intense competition from both established players and new entrants, fluctuating cannabis prices that can impact profitability, and the ever-changing regulatory environment at both the state and federal levels. The company's negative profit margins and high beta further highlight its financial instability and volatility, requiring careful monitoring of its financial performance and strategic initiatives.

Beliebte Aktien

Alle Aktien anzeigen →